Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - Kenya

Kenya

In Kenya, the revenue in the Cold & Cough Remedies market market reaches US$48.86m in 2024.
It is projected to experience an annual growth rate of 6.39% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, amounting to US$11,190.00m in 2024.
In terms of per capita figures, each person in Kenya generates revenues of US$0.87 in 2024.
Kenya's cold and cough remedies market is witnessing a surge in demand due to the country's high prevalence of respiratory infections.

Key regions: Australia, Japan, India, Brazil, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Cold & Cough Remedies market in Kenya is experiencing significant development and growth.

Customer preferences: Customers in Kenya have shown a strong preference for over-the-counter (OTC) cold and cough remedies. This can be attributed to the ease of access and affordability of these products. Kenyan consumers value convenience and self-medication, and OTC remedies provide them with the ability to treat their symptoms without visiting a healthcare professional. Additionally, the increasing awareness about the importance of managing cold and cough symptoms has led to a higher demand for these remedies.

Trends in the market: One of the major trends in the Cold & Cough Remedies market in Kenya is the growing popularity of herbal and natural remedies. Kenyan consumers are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives. This trend is driven by the perception that herbal remedies are safer and have fewer side effects compared to chemical-based products. Manufacturers are capitalizing on this trend by introducing herbal and natural remedies in the market.Another trend in the market is the increasing availability of cold and cough remedies in various forms such as tablets, syrups, and lozenges. This allows consumers to choose the form that best suits their preferences and needs. For example, individuals who have difficulty swallowing pills can opt for syrups or lozenges. This diversification of product offerings caters to a wider range of consumer preferences and increases the overall market demand.

Local special circumstances: The prevalence of cold and cough in Kenya is influenced by various factors such as climate, lifestyle, and environmental conditions. Kenya experiences a tropical climate with distinct wet and dry seasons. The wet season, characterized by increased rainfall, leads to a higher incidence of respiratory illnesses. This creates a seasonal demand for cold and cough remedies, with sales peaking during the wet season.Additionally, the high levels of air pollution in urban areas contribute to respiratory problems and increase the need for cold and cough remedies. The rapid urbanization and industrialization in Kenya have led to an increase in pollution levels, especially in major cities like Nairobi. This factor further drives the demand for remedies that alleviate cold and cough symptoms.

Underlying macroeconomic factors: The development of the Cold & Cough Remedies market in Kenya is also influenced by macroeconomic factors. The steady economic growth in the country has resulted in an increase in disposable income, allowing consumers to spend more on healthcare products. This has positively impacted the demand for cold and cough remedies as consumers are willing to invest in their health and well-being.Furthermore, the expanding middle class in Kenya has contributed to the growth of the market. As more individuals move up the income ladder, they have greater access to healthcare products and are more likely to prioritize their health needs. The rising middle class population in Kenya presents a significant market opportunity for manufacturers and retailers of cold and cough remedies.In conclusion, the Cold & Cough Remedies market in Kenya is developing due to customer preferences for OTC remedies, the trend towards herbal and natural products, the availability of remedies in different forms, local special circumstances such as climate and pollution, and underlying macroeconomic factors such as economic growth and the expanding middle class. These factors collectively contribute to the growth and expansion of the market in Kenya.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.